Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
|Title||A Study of VB-111 With Paclitaxel vs Paclitaxel for Treatment of Recurrent Platinum-Resistant Ovarian Cancer (OVAL) (OVAL)|
|Recruitment||Active, not recruiting|
|Sponsors||Vascular Biogenics Ltd. operating as VBL Therapeutics|
|Age Groups:||adult | senior|
|Covered Countries||USA | ESP|